Lifelong estradiol exposure and risk of depressive symptoms during the transition to menopause and postmenopause.

about

Analysis of Sociodemographic, Psychological, and Genetic Factors Contributing to Depressive symptoms in Pre-, Peri- and Postmenopausal Women.Depression During and After the Perimenopause: Impact of Hormones, Genetics, and Environmental Determinants of Disease

P2860

Q53830910-B9629331-A913-4C54-9841-D73D312267AB Q58551812-100B56A0-B3AB-4585-8FE2-547F523F114E

P2860

Lifelong estradiol exposure and risk of depressive symptoms during the transition to menopause and postmenopause.

Item

http://www.wikidata.org/entity/Q38673877

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Lifelong estradiol exposure an ...... o menopause and postmenopause.

@en

type

Item

label

Lifelong estradiol exposure an ...... o menopause and postmenopause.

@en

prefLabel

Lifelong estradiol exposure an ...... o menopause and postmenopause.

@en

P1476

Lifelong estradiol exposure an ...... o menopause and postmenopause.

@en

P2093

Claudio N Soares

http://www.w3.org/2001/XMLSchema#string

Howard M Kravitz

http://www.w3.org/2001/XMLSchema#string

John F Randolph

http://www.w3.org/2001/XMLSchema#string

Joyce T Bromberger

http://www.w3.org/2001/XMLSchema#string

Katherine Leung

http://www.w3.org/2001/XMLSchema#string

Sybil L Crawford

http://www.w3.org/2001/XMLSchema#string

Wendy K Marsh

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of Estradiol Withdrawal on Mood in Women With Past Perimenopausal Depression: A Randomized Clinical Trial.

Factors associated with early menopause.

Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial.

Predictors of first lifetime episodes of major depression in midlife women

Menopause and breast cancer risk.

ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation.

Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN).

Puberty, ovarian steroids, and stress.

Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.

Depressive symptoms during the menopausal transition: the Study of Women's Health Across the Nation (SWAN).

P31

scholarly article

P356

10.1097/GME.0000000000000929

http://www.w3.org/2001/XMLSchema#string

P407

English

P50

Hadine Joffe

P577

2017-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28719421

http://www.w3.org/2001/XMLSchema#string

P932

5860642

http://www.w3.org/2001/XMLSchema#string

Lifelong estradiol exposure and risk of depressive symptoms during the transition to menopause and postmenopause.

about

P2860

P2860

Lifelong estradiol exposure and risk of depressive symptoms during the transition to menopause and postmenopause.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P50

P577

P698

P932